Exhibit 99.1
March 6, 2008
United States Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street N.W.
Washington, D.C. 20549
U.S.A.
To Whom It May Concern:
Re: Stellar Pharmaceuticals Inc.
This is to confirm that Mintz & Partners, LLP (having merged effective January 29, 2008 with Deloitte & Touche LLP) confirms that it agrees with the disclosure contained in the report of Stellar Pharmaceuticals Inc. filed on Form 8-k entitled “Changes in Registrant’s Certifying Accountant”.
Yours very truly, | |
| |
/s/ MINTZ & PARTNERS LLP | |
|
|
A Pre-decessor firm to Deloitte & Touche LLP | |
Per: Allan Cheskes, C.A. |
|
Partner |
|
|
|
Direct Line: 416-644-4381 | |
Direct Fax: 416-644-4382 | |
E-Mail: allan_cheskes@mintzca.com |